|Articles|November 15, 2002

Bent on Biologics: Attacking the Pathogenesis

Fledgling drugs like infliximab offer more hope than traditional methods

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME